Global Antimalarial Medication Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antimalarial Medication market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antimalarial Medication market."
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
Antimalarial medication are the medicines used to prevent and treat malaria. 

The global Antimalarial Medication market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antimalarial Medication volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antimalarial Medication market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline
    F. Hoffmann-La Roche
    Novartis
    Pfizer
    Sun Pharmaceutical Industries
    Merck
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Plasmodium Falciparum
    Plasmodium Malariae
    Plasmodium Vivax
    Plasmodium Ovale

Segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    E- Commerce
    Others